147 related articles for article (PubMed ID: 32485144)
1. Risk evaluation of the use of complementary and alternative medicines in cancer.
Renet S; de Chevigny A; Hoacoglu S; Belkarfa AL; Jardin-Szucs M; Bezie Y; Jouveshomme S
Ann Pharm Fr; 2021 Jan; 79(1):44-52. PubMed ID: 32485144
[TBL] [Abstract][Full Text] [Related]
2. Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?
McLay JS; Stewart D; George J; Rore C; Heys SD
Eur J Clin Pharmacol; 2012 May; 68(5):811-9. PubMed ID: 22166933
[TBL] [Abstract][Full Text] [Related]
3. [A French survey on the resort of oral alternative complementary medicines used in children with cancer].
Philibert C; Hoegy D; Philippe M; Marec-Bérard P; Bleyzac N
Bull Cancer; 2015 Oct; 102(10):854-62. PubMed ID: 26387822
[TBL] [Abstract][Full Text] [Related]
4. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.
Ali-Shtayeh MS; Jamous RM; Salameh NM; Jamous RM; Hamadeh AM
J Ethnopharmacol; 2016 Jul; 187():104-22. PubMed ID: 27125594
[TBL] [Abstract][Full Text] [Related]
5. Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study : Complementary and alternative medicine in oncology.
Bozza C; Gerratana L; Basile D; Vitale MG; Bartoletti M; Agostinetto E; Russo S; Follador A; De Carlo E; Pella N; Sottile R; Fasola G; Puglisi F
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2029-2047. PubMed ID: 30043280
[TBL] [Abstract][Full Text] [Related]
6. [Complementary and alternative medicine use in two French pediatric oncology centers: A common practice].
Menut V; Seigneur E; Gras Leguen C; Orbach D; Thebaud E
Bull Cancer; 2019 Mar; 106(3):189-200. PubMed ID: 30771881
[TBL] [Abstract][Full Text] [Related]
7. Complementary and alternative medications consumed by renal patients in southern Germany.
Nowack R; Ballé C; Birnkammer F; Koch W; Sessler R; Birck R
J Ren Nutr; 2009 May; 19(3):211-9. PubMed ID: 19251442
[TBL] [Abstract][Full Text] [Related]
8. Use of complementary and alternative medicine in cancer: A Tunisian single-center experience.
Labidi S; Ennouri S; Rachdi H; El Benna H; Mejri N; Daoud N; Berrazaga Y; Boussen H
Bull Cancer; 2020 Feb; 107(2):209-214. PubMed ID: 32000968
[TBL] [Abstract][Full Text] [Related]
9. The use of complementary and alternative medicine by patients in routine care and the risk of interactions.
Firkins R; Eisfeld H; Keinki C; Buentzel J; Hochhaus A; Schmidt T; Huebner J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):551-557. PubMed ID: 29356888
[TBL] [Abstract][Full Text] [Related]
10. [Complementary and alternative medicines taken by cancer patients].
Simon L; Prebay D; Beretz A; Bagot JL; Lobstein A; Rubinstein I; Schraub S
Bull Cancer; 2007 May; 94(5):483-8. PubMed ID: 17535787
[TBL] [Abstract][Full Text] [Related]
11. Attitude of healthcare professionals toward the use of complementary and alternative medication during anti-cancer therapy.
Sont OM; Rombouts MD; Crul M
J Oncol Pharm Pract; 2024 Jun; 30(4):628-635. PubMed ID: 37259518
[TBL] [Abstract][Full Text] [Related]
12. An assessment of the impact of herb-drug combinations used by cancer patients.
Alsanad SM; Howard RL; Williamson EM
BMC Complement Altern Med; 2016 Oct; 16(1):393. PubMed ID: 27756298
[TBL] [Abstract][Full Text] [Related]
13. Web Conversations About Complementary and Alternative Medicines and Cancer: Content and Sentiment Analysis.
Mazzocut M; Truccolo I; Antonini M; Rinaldi F; Omero P; Ferrarin E; De Paoli P; Tasso C
J Med Internet Res; 2016 Jun; 18(6):e120. PubMed ID: 27311444
[TBL] [Abstract][Full Text] [Related]
14. Perception of cancer patients of their disease, self-efficacy and locus of control and usage of complementary and alternative medicine.
Ebel MD; Rudolph I; Keinki C; Hoppe A; Muecke R; Micke O; Muenstedt K; Huebner J
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1449-55. PubMed ID: 25702103
[TBL] [Abstract][Full Text] [Related]
15. Patterns of complementary and alternative medicine use among patients undergoing cancer treatment.
Corner J; Yardley J; Maher EJ; Roffe L; Young T; Maslin-Prothero S; Gwilliam C; Haviland J; Lewith G
Eur J Cancer Care (Engl); 2009 May; 18(3):271-9. PubMed ID: 19432919
[TBL] [Abstract][Full Text] [Related]
16. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
[TBL] [Abstract][Full Text] [Related]
17. Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma.
Loquai C; Dechent D; Garzarolli M; Kaatz M; Kaehler KC; Kurschat P; Meiss F; Stein A; Nashan D; Micke O; Muecke R; Muenstedt K; Stoll C; Schmidtmann I; Huebner J
Med Oncol; 2016 May; 33(5):52. PubMed ID: 27090799
[TBL] [Abstract][Full Text] [Related]
18. Safety of complementary and alternative medicine in children: A 16-years retrospective analysis of the Italian Phytovigilance system database.
Lombardi N; Crescioli G; Bettiol A; Menniti-Ippolito F; Maggini V; Gallo E; Mugelli A; Vannacci A; Firenzuoli F
Phytomedicine; 2019 Aug; 61():152856. PubMed ID: 31035051
[TBL] [Abstract][Full Text] [Related]
19. Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care.
Wortmann JK; Bremer A; Eich HT; Wortmann HP; Schuster A; Fühner J; Büntzel J; Muecke R; Prott FJ; Huebner J
Med Oncol; 2016 Jul; 33(7):78. PubMed ID: 27300549
[TBL] [Abstract][Full Text] [Related]
20. Surveys of Cancer Patients and Cancer Health Care Providers Regarding Complementary Therapy Use, Communication, and Information Needs.
King N; Balneaves LG; Levin GT; Nguyen T; Nation JG; Card C; Truant T; Carlson LE
Integr Cancer Ther; 2015 Nov; 14(6):515-24. PubMed ID: 26069277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
